Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Preventive Medicine
|
August 26, 2023
The prevalence and clustering of alcohol consumption, gambling, smoking, and excess weight in an English adult population
Robyn Burton, Casey Sharpe, Nick Sheron, et al.
Journal of Hepatology
|
May 20, 2018
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
Laura Pimpin, Helena Cortez-Pinto, Francesco Negro, et al.
Lancet (London, England)
|
February 16, 2013
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries
Rob Moodie, David Stuckler, Carlos Monteiro, et al.
Journal of Medical Virology
|
December 22, 2007
Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: time for routine testing?
Aminda N De Silva, Ajay K Muddu, John P Iredale, et al.
BMJ Open
|
February 12, 2021
Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data
Theresa Hydes, Michael Moore, Beth Stuart, et al.
BMC Public Health
|
May 10, 2024
The relationship between the price and demand of alcohol, tobacco, unhealthy food, sugar-sweetened beverages, and gambling: an umbrella review of systematic reviews
Robyn Burton, Casey Sharpe, Saloni Bhuptani, et al.
The Journal of Family Planning and Reproductive Health Care
|
August 12, 2015
Assessing feasibility and acceptability of a brief intervention for risky alcohol consumption in sexual health clinic attendees: a randomised controlled trial
Paul Roderick, Sangeetha S Sundaram, Borislav D Dimitrov, et al.
Plos One
|
December 22, 2018
Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care
Magdy El-Gohary, Mike Moore, Paul Roderick, et al.
Plos One
|
October 3, 2013
Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease
Aloysious Aravinthan, Giada Pietrosi, Matthew Hoare, et al.
BMC Public Health
|
June 5, 2015
Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study
Penny A Cook, Michela Morleo, David Billington, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Preventive Medicine
|
August 26, 2023
The prevalence and clustering of alcohol consumption, gambling, smoking, and excess weight in an English adult population
Robyn Burton, Casey Sharpe, Nick Sheron, et al.
Journal of Hepatology
|
May 20, 2018
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
Laura Pimpin, Helena Cortez-Pinto, Francesco Negro, et al.
Lancet (London, England)
|
February 16, 2013
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries
Rob Moodie, David Stuckler, Carlos Monteiro, et al.
Journal of Medical Virology
|
December 22, 2007
Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: time for routine testing?
Aminda N De Silva, Ajay K Muddu, John P Iredale, et al.
BMJ Open
|
February 12, 2021
Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data
Theresa Hydes, Michael Moore, Beth Stuart, et al.
BMC Public Health
|
May 10, 2024
The relationship between the price and demand of alcohol, tobacco, unhealthy food, sugar-sweetened beverages, and gambling: an umbrella review of systematic reviews
Robyn Burton, Casey Sharpe, Saloni Bhuptani, et al.
The Journal of Family Planning and Reproductive Health Care
|
August 12, 2015
Assessing feasibility and acceptability of a brief intervention for risky alcohol consumption in sexual health clinic attendees: a randomised controlled trial
Paul Roderick, Sangeetha S Sundaram, Borislav D Dimitrov, et al.
Plos One
|
December 22, 2018
Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care
Magdy El-Gohary, Mike Moore, Paul Roderick, et al.
Plos One
|
October 3, 2013
Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease
Aloysious Aravinthan, Giada Pietrosi, Matthew Hoare, et al.
BMC Public Health
|
June 5, 2015
Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study
Penny A Cook, Michela Morleo, David Billington, et al.
Page
of 8